IMMP Intensive Medicines Monitoring Programme: Lipid lowering agents and reasons for cessation of therapy. NZ Fam Physician 1994;21(1):29.
Monthly Archives: November 2013
1984 Coulter DM, Edwards IR
IMMP Amiodarone: An appraisal of the New Zealand experience.Hospital Therapeutics 1984 Jul:5-9.
1990 Coulter DM
IMMP Intensive Medicines Monitoring Programme: Experience with aciclovir.NZ Fam Physician 1990;17(1):31.
1993 Wood RS, Coulter DM.
IMMP Cough and bronchospasm adverse reactions to ACE inhibitors – a controlled case comparison study [abstract]. The Royal Australasian College of Physicians and Special Societies
1996 Pillans PI, Coulter DM, Black P
IMMP Angioedema and urticaria with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 1996;51:123-26.
1993 Wood RS, Coulter DM
IMMP Bronchospasm and cough as adverse reactions to ACE inhibitors – a controlled retrospective cohort study [abstract]. The Royal Australasian College of Physicians and Special Societies
1993 Wood RS
IMMP Bronchospasm and cough as adverse reactions to ACE inhibitors – a controlled retrospective cohort study. Cardiac Society of Aust & NZ 1993; October:587.
1993 Coulter DM, Pillans P
IMMP Angiotensin-converting enzyme inhibitors and psoriasis [letter].NZ Med J 1993;106:392-3.
1990 Coulter DM
IMMP Intensive Medicines Monitoring Programme: A review of reactions to ACE inhibitors. NZ Fam Physician 1990;17(3):139.
1990 Coulter DM
IMMP Intensive Medicines Monitoring Programme: ACE inhibitors and pancreatitis. NZ Fam Physician 1990;17(2):87.